277 related articles for article (PubMed ID: 7480537)
1. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.
Corbett R; Camacho F; Woods AT; Kerman LL; Fishkin RJ; Brooks K; Dunn RW
Psychopharmacology (Berl); 1995 Jul; 120(1):67-74. PubMed ID: 7480537
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
3. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
4. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
[TBL] [Abstract][Full Text] [Related]
5. Histamine H3 receptor antagonists display antischizophrenic activities in rats treated with MK-801.
Mahmood D; Akhtar M; Jahan K; Goswami D
J Basic Clin Physiol Pharmacol; 2016 Sep; 27(5):463-71. PubMed ID: 27089413
[TBL] [Abstract][Full Text] [Related]
6. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Ninan I; Kulkarni SK
Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.
Ninan I; Jardemark KE; Wang RY
Neuropharmacology; 2003 Mar; 44(4):462-72. PubMed ID: 12646283
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
9. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
10. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
11. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.
Farber NB; Foster J; Duhan NL; Olney JW
Schizophr Res; 1996 Jul; 21(1):33-7. PubMed ID: 8998274
[TBL] [Abstract][Full Text] [Related]
13. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
[TBL] [Abstract][Full Text] [Related]
14. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
15. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
16. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
17. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
Abekawa T; Ito K; Koyama T
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
[TBL] [Abstract][Full Text] [Related]
18. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.
Zangrando J; Carvalheira R; Labbate G; Medeiros P; Longo BM; Melo-Thomas L; Silva RC
Behav Brain Res; 2013 Nov; 257():77-82. PubMed ID: 24045065
[TBL] [Abstract][Full Text] [Related]
20. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
